Cargando…
The efficacy and safety of ciclesonide for the treatment of perennial allergic rhinitis: a systematic review and meta-analysis()
INTRODUCTION: Allergic rhinitis is a chronic inflammatory disease which affects 1 out of 6 individuals. Perennial allergic rhinitis accounts for 40% of AR cases. Ciclesonide is one of the relatively new intranasal steroid for allergic rhinitis. OBJECTIVE: The purpose of this study was to evaluate th...
Autores principales: | Yang, Qi, Wang, Fei, Li, Bin, Wu, Wenbin, Xie, Dengpiao, He, Li, Xiang, Nan, Dong, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9442893/ https://www.ncbi.nlm.nih.gov/pubmed/30522830 http://dx.doi.org/10.1016/j.bjorl.2018.10.008 |
Ejemplares similares
-
Intranasal ciclesonide for allergic rhinitis
por: Williams, Ben, et al.
Publicado: (2008) -
154 A 26-Week Study Evaluating the Safety and Efficacy of Ciclesonide Hydrofluoralkane Nasal Aerosol in Subjects With Perennial Allergic Rhinitis
por: Berger, William, et al.
Publicado: (2012) -
146 A 6-Week Study of the Efficacy and Safety of Ciclesonide Hydrofluoroalkane Nasal Aerosol in the Relief of Nasal Symptoms of Perennial Allergic Rhinitis
por: Mohar, Dale, et al.
Publicado: (2012) -
New treatment options in allergic rhinitis: patient considerations and the role of ciclesonide
por: Braido, F, et al.
Publicado: (2008) -
Comparison of Intranasal Ciclesonide, Oral Levocetirizine, and Combination Treatment for Allergic Rhinitis
por: Kim, Chang-Hoon, et al.
Publicado: (2015)